Contributions to the treatment of cancer of the head and neck. Regional antimetabolite infusion

H F OETTGEN. East Afr Med J. 1961 Nov.

. 1961 Nov:38:493-500.

No abstract available

Similar articles

Regional infusion chemotherapy for cancer of the head and neck.
Donegan WL. Donegan WL. Surg Annu. 1975;7:137-73. Surg Annu. 1975. PMID: 1101400 Review.
Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin.
Hrovatin E, Viel E, Lestuzzi C, Tartuferi L, Zardo F, Brieda M, Dametto E, Piazza R, Antonini-Canterin F, Vaccher E, Meneguzzo N, Nicolosi GL. Hrovatin E, et al. J Cardiovasc Med (Hagerstown). 2006 Aug;7(8):637-40. doi: 10.2459/01.JCM.0000237914.12915.dd. J Cardiovasc Med (Hagerstown). 2006. PMID: 16858245
Contributions to the treatment of cancer of the head and neck. Nitrogen mustard toxicity and bone marrow infusion.
CLIFT RA. CLIFT RA. East Afr Med J. 1961 Nov;38:500-2. East Afr Med J. 1961. PMID: 13879952 No abstract available.
Chemotherapy in the treatment of head and neck cancer.
Daly JF. Daly JF. Minn Med. 1967 Jun;50(6):1016-9. Minn Med. 1967. PMID: 6041495 No abstract available.
[The present situation of neoadjuvant therapy for head and neck carcinoma].
Rikimaru F, Tomita K. Rikimaru F, et al. Gan To Kagaku Ryoho. 2007 Oct;34(10):1535-7. Gan To Kagaku Ryoho. 2007. PMID: 17940367 Review. Japanese.

[REGIONAL CHEMOTHERAPY OF MALIGNANT TUMORS. I. PROLONGED INTRA-ARTERIAL INFUSION OF ANTIMETABOLITES].
OETTGEN HF. OETTGEN HF. Klin Wochenschr. 1964 Mar 1;42:211-8. doi: 10.1007/BF01487945. Klin Wochenschr. 1964. PMID: 14169590 German. No abstract available.